Wearable Technology and Its Potential Role in Cardiovascular Health Monitoring and Disease Management
Health Science Reports · 2025-11 · 8 (11)
DOI: 10.1002/hsr2.71486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 19.11.2025. Verfasst von Abubakar Nazir und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine King Edward Medical University Pakistan. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cardiovascular disease (CVD) remains the foremost cause of death globally, accounting for approximately 17.9 million deaths in 2019, 32% of all global fatalities with myocardial infarction and stroke constituting 85% of these. The disproportionate burden in low‐ and middle‐income countries underscores the urgent need for scalable, technology‐driven preventive and diagnostic strategies. Wearable technology represents a paradigm shift in cardiovascular health monitoring by facilitating continuous, real‐time physiological assessment and early disease detection.
Objectives
To critically synthesize and appraise the current evidence on wearable technology for cardiovascular disease prevention, early detection, and long‐term management, emphasizing its clinical applications, integration with digital ecosystems, and implications for precision cardiology.
Methods
A comprehensive, multi‐database literature search was conducted spanning January 2000 to 2025. The electronic databases PubMed, Scopus, Web of Science, ScienceDirect, IEEE Xplore, and Cochrane Library, along with Google Scholar for gray literature, were systematically queried. Search terms combined MeSH and free‐text keywords, including “wearable technology,” “cardiovascular monitoring,” “arrhythmia detection,” “heart failure,” “remote patient monitoring,” “artificial intelligence,” and “digital health.” Study selection followed PRISMA‐aligned screening principles, with inclusion criteria encompassing peer‐reviewed clinical trials, systematic reviews, and technology validation studies focusing on cardiovascular applications of wearable devices. Exclusion criteria included nonhuman studies, non‐English papers, and reports lacking clinical or technical relevance. Data extraction was independently performed by two reviewers, emphasizing device characteristics, monitoring parameters, diagnostic accuracy, patient outcomes, and integration with healthcare infrastructure. Methodological quality was appraised using standardized critical‐appraisal tools. Supplementary evidence was retrieved from the World Health Organization, U.S. FDA, and European Medicines Agency to contextualize regulatory and translational perspectives.
Results
Wearable devices demonstrated robust capability in continuous cardiovascular monitoring, enabling early detection of arrhythmias, hypertension, heart failure, and ischemic events. Devices integrating photoplethysmography, ECG, biosensors, and machine‐learning algorithms significantly enhanced diagnostic sensitivity while improving patient engagement and lifestyle modification. Integration with telemedicine, artificial intelligence (AI), and the Internet of Medical Things (IoMT) enabled predictive analytics and personalized care. Major limitations included variability in data accuracy, interoperability barriers, regulatory heterogeneity, and privacy vulnerabilities. Nonetheless, aggregated evidence indicates substantial improvement in early detection, remote disease management, and patient outcomes.
Conclusion
Wearable technology stands at the frontier of precision cardiovascular medicine, offering continuous, noninvasive, and data‐driven insights into patient health. The convergence of AI, IoMT, and real‐world data integration positions wearables as indispensable tools for risk stratification and remote management. Future work should prioritize standardized validation frameworks, cybersecurity reinforcement, and equitable global accessibility to maximize clinical impact and population‐level benefits.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine King Edward Medical University Pakistan.
- Department of Medicine The Jewish Hospital- Mercy Health, Cincinnati Ohio.
- Oli Health Magazine Organization, Research and Education Kigali Rwanda.
- Faculty of Basic Medical Sciences University of Ilorin Ilorin Nigeria.
- Federal Medical Centre, Abeokuta.
- Faculty of Clinical Sciences Obafemi Awolowo University Ile-Ife Nigeria.
ORCID-Profile: Abubakar Nazir, Mubarak Jolayemi Mustapha, Sodiq Olatunbosun Lawal, Misbahudeen Olohuntoyin AbdulKareem, Mustapha Fatihi Bamigbola
Zitieren
APA
Nazir, A., Nazir, A., Shah Wali Jamal, M., Sadiq, S. U. R., Aman, S., Mustapha, M. J., Lawal, S. O., AbdulKareem, M. O., & Bamigbola, M. F. (2025). Wearable Technology and Its Potential Role in Cardiovascular Health Monitoring and Disease Management. Health Science Reports, 8(11). https://doi.org/10.1002/hsr2.71486
Vancouver
Nazir A, Nazir A, Shah Wali Jamal M, Sadiq SUR, Aman S, Mustapha MJ, et al. Wearable Technology and Its Potential Role in Cardiovascular Health Monitoring and Disease Management. Health Science Reports. 2025;8(11). doi:10.1002/hsr2.71486
BibTeX
@article{Nazir2025,
author = {Nazir, Abubakar and Nazir, Awais and Shah Wali Jamal, Muhammad and Sadiq, Safi Ur Rehman and Aman, Shafaq and Mustapha, Mubarak Jolayemi and Lawal, Sodiq Olatunbosun and AbdulKareem, Misbahudeen Olohuntoyin and Bamigbola, Mustapha Fatihi},
title = {Wearable Technology and Its Potential Role in Cardiovascular Health Monitoring and Disease Management},
journal = {Health Science Reports},
year = {2025},
volume = {8},
number = {11},
doi = {10.1002/hsr2.71486}
}
EUVIMED